STAAR Surgical Company (STAA)
USD 24.26
(-4.64%)
USD 24.26
(-4.64%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 33.22 Million USD | -33.58% |
| 2022 | 48.31 Million USD | 25.22% |
| 2021 | 36.98 Million USD | 343.83% |
| 2020 | 9.86 Million USD | -43.99% |
| 2019 | 15.55 Million USD | 62.39% |
| 2018 | 9.05 Million USD | 1002.83% |
| 2017 | -277 Thousand USD | 88.2% |
| 2016 | -9.66 Million USD | -336.77% |
| 2015 | -3.07 Million USD | 58.58% |
| 2014 | -5.13 Million USD | -251.21% |
| 2013 | 3.43 Million USD | 109.37% |
| 2012 | 1.74 Million USD | -68.08% |
| 2011 | 5.49 Million USD | 3420.92% |
| 2010 | -379 Thousand USD | -306.76% |
| 2009 | 364 Thousand USD | 100.45% |
| 2008 | -17.13 Million USD | -50.74% |
| 2007 | -12.18 Million USD | 4.4% |
| 2006 | -10.87 Million USD | -31.5% |
| 2005 | -7.31 Million USD | -15.72% |
| 2004 | -7.33 Million USD | -144.79% |
| 2003 | -3.62 Million USD | -33.19% |
| 2002 | -4 Million USD | -400.13% |
| 2001 | -6.93 Million USD | 106.76% |
| 2000 | -16.45 Million USD | -244.82% |
| 1999 | 8.2 Million USD | -23.3% |
| 1998 | 11 Million USD | 5.1% |
| 1997 | 12.8 Million USD | -16.95% |
| 1996 | 12.4 Million USD | 47.5% |
| 1995 | 8.6 Million USD | 33.33% |
| 1994 | 6.8 Million USD | 185.71% |
| 1993 | 2.8 Million USD | 132.31% |
| 1992 | -3.8 Million USD | 38.1% |
| 1991 | -10.6 Million USD | -194.44% |
| 1990 | -3.6 Million USD | -33.33% |
| 1989 | -2.7 Million USD | -125.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.04 Million USD | -108.87% |
| 2024 Q2 | 13.42 Million USD | 1385.44% |
| 2024 Q3 | 5.68 Million USD | -44.57% |
| 2023 Q3 | 9.02 Million USD | -24.41% |
| 2023 FY | - USD | -33.58% |
| 2023 Q4 | 11.77 Million USD | 30.47% |
| 2023 Q1 | 3.88 Million USD | 558.8% |
| 2023 Q2 | 11.93 Million USD | 207.15% |
| 2022 Q3 | 16.91 Million USD | -15.06% |
| 2022 FY | - USD | 25.22% |
| 2022 Q1 | 14.03 Million USD | 51.64% |
| 2022 Q2 | 19.91 Million USD | 41.96% |
| 2022 Q4 | -847 Thousand USD | -105.01% |
| 2021 Q1 | 9.64 Million USD | 119.46% |
| 2021 Q2 | 11.67 Million USD | 21.09% |
| 2021 FY | - USD | 343.83% |
| 2021 Q3 | 9.37 Million USD | -19.73% |
| 2021 Q4 | 9.25 Million USD | -1.29% |
| 2020 FY | - USD | -43.99% |
| 2020 Q2 | -683 Thousand USD | -732.41% |
| 2020 Q3 | 5.18 Million USD | 858.57% |
| 2020 Q4 | 4.39 Million USD | -15.19% |
| 2020 Q1 | 108 Thousand USD | -96.22% |
| 2019 Q2 | 5.37 Million USD | 76.47% |
| 2019 Q1 | 3.04 Million USD | 43.27% |
| 2019 FY | - USD | 62.39% |
| 2019 Q4 | 2.85 Million USD | -40.42% |
| 2019 Q3 | 4.79 Million USD | -10.67% |
| 2018 Q4 | 2.12 Million USD | -1.85% |
| 2018 Q2 | 4.17 Million USD | 191.0% |
| 2018 Q1 | 1.43 Million USD | 388.53% |
| 2018 FY | - USD | 1002.83% |
| 2018 Q3 | 2.16 Million USD | -48.14% |
| 2017 FY | - USD | 88.2% |
| 2017 Q4 | -497 Thousand USD | -134.25% |
| 2017 Q3 | 1.45 Million USD | 270.31% |
| 2017 Q2 | -852 Thousand USD | 28.94% |
| 2017 Q1 | -1.19 Million USD | -155.51% |
| 2016 Q4 | 2.16 Million USD | 341.88% |
| 2016 Q1 | -9.43 Million USD | -1101.06% |
| 2016 Q2 | -1.12 Million USD | 88.06% |
| 2016 FY | - USD | -336.77% |
| 2016 Q3 | -893 Thousand USD | 20.69% |
| 2015 Q1 | -891 Thousand USD | 70.79% |
| 2015 Q3 | -1.13 Million USD | -8.92% |
| 2015 FY | - USD | 58.58% |
| 2015 Q4 | 942 Thousand USD | 182.92% |
| 2015 Q2 | -1.04 Million USD | -17.06% |
| 2014 Q3 | -1.49 Million USD | -141.52% |
| 2014 Q1 | -614 Thousand USD | -2.85% |
| 2014 Q2 | -619 Thousand USD | -0.81% |
| 2014 FY | - USD | -251.21% |
| 2014 Q4 | -3.05 Million USD | -104.01% |
| 2013 Q4 | -597 Thousand USD | -165.89% |
| 2013 FY | - USD | 109.37% |
| 2013 Q1 | 1.69 Million USD | 414.47% |
| 2013 Q2 | 1.42 Million USD | -16.22% |
| 2013 Q3 | 906 Thousand USD | -36.2% |
| 2012 Q2 | -157 Thousand USD | -120.39% |
| 2012 Q1 | 770 Thousand USD | -47.15% |
| 2012 Q4 | -539 Thousand USD | -218.98% |
| 2012 Q3 | 453 Thousand USD | 388.54% |
| 2012 FY | - USD | -68.08% |
| 2011 FY | - USD | 3420.92% |
| 2011 Q3 | 1.23 Million USD | -25.62% |
| 2011 Q2 | 1.66 Million USD | 129.38% |
| 2011 Q4 | 1.45 Million USD | 17.78% |
| 2011 Q1 | 725 Thousand USD | 1328.81% |
| 2010 Q2 | -208 Thousand USD | -128.93% |
| 2010 FY | - USD | -306.76% |
| 2010 Q4 | -59 Thousand USD | 90.28% |
| 2010 Q3 | -607 Thousand USD | -191.83% |
| 2010 Q1 | 719 Thousand USD | 15.59% |
| 2009 Q1 | -359 Thousand USD | 96.84% |
| 2009 FY | - USD | 100.45% |
| 2009 Q4 | 622 Thousand USD | 303.93% |
| 2009 Q3 | -305 Thousand USD | -365.22% |
| 2009 Q2 | 115 Thousand USD | 132.03% |
| 2008 FY | - USD | -50.74% |
| 2008 Q1 | -3.97 Million USD | -40.2% |
| 2008 Q2 | -1.22 Million USD | 69.21% |
| 2008 Q3 | -32 Thousand USD | 97.38% |
| 2008 Q4 | -11.36 Million USD | -35400.0% |
| 2007 FY | - USD | 4.4% |
| 2007 Q1 | -2.63 Million USD | 38.98% |
| 2007 Q2 | -2.59 Million USD | 1.22% |
| 2007 Q3 | -2.93 Million USD | -13.08% |
| 2007 Q4 | -2.83 Million USD | 3.61% |
| 2006 Q4 | -4.31 Million USD | -100.19% |
| 2006 FY | - USD | -31.5% |
| 2006 Q3 | -2.15 Million USD | 12.44% |
| 2006 Q1 | -2.58 Million USD | 13.87% |
| 2006 Q2 | -2.46 Million USD | 4.76% |
| 2005 Q4 | -2.99 Million USD | -10.3% |
| 2005 FY | - USD | -15.72% |
| 2005 Q2 | -1.42 Million USD | 12.13% |
| 2005 Q3 | -2.71 Million USD | -91.48% |
| 2005 Q1 | -1.61 Million USD | 42.98% |
| 2004 Q2 | -2.62 Million USD | -454.43% |
| 2004 Q4 | -2.83 Million USD | -74.19% |
| 2004 Q1 | -474 Thousand USD | 53.44% |
| 2004 FY | - USD | -144.79% |
| 2004 Q3 | -1.62 Million USD | 38.09% |
| 2003 Q2 | -497 Thousand USD | -1229.55% |
| 2003 FY | - USD | -33.19% |
| 2003 Q1 | 37 Thousand USD | -82.19% |
| 2003 Q3 | -1.75 Million USD | -235.41% |
| 2003 Q4 | -1.71 Million USD | 38.93% |
| 2002 Q3 | -1.05 Million USD | -92.83% |
| 2002 Q1 | -1.12 Million USD | -128.6% |
| 2002 Q2 | -2.06 Million USD | 54.24% |
| 2002 FY | - USD | -400.13% |
| 2002 Q4 | 138 Thousand USD | 125.52% |
| 2001 Q3 | 110 Thousand USD | 142.45% |
| 2001 Q1 | 1.05 Million USD | 103.85% |
| 2001 Q2 | -6.13 Million USD | -700.69% |
| 2001 FY | - USD | 106.76% |
| 2001 Q4 | -1.4 Million USD | 47.48% |
| 2000 Q3 | 2.03 Million USD | -47.7% |
| 2000 Q4 | -13.94 Million USD | -1405.27% |
| 2000 FY | - USD | -244.82% |
| 2000 Q2 | -19.87 Million USD | 143.2% |
| 2000 Q1 | 1.56 Million USD | 77.48% |
| 1999 Q3 | 2.1 Million USD | 0.0% |
| 1999 FY | - USD | -23.3% |
| 1999 Q4 | 1.3 Million USD | -59.09% |
| 1999 Q2 | 2.2 Million USD | -4.35% |
| 1999 Q1 | 2.32 Million USD | 866.67% |
| 1998 Q1 | 4 Million USD | 178.57% |
| 1998 FY | - USD | 5.1% |
| 1998 Q4 | 500 Thousand USD | -110.71% |
| 1998 Q3 | 2.5 Million USD | -24.32% |
| 1998 Q2 | 3.8 Million USD | -5.13% |
| 1997 Q3 | 4.2 Million USD | 16.22% |
| 1997 Q4 | 1.4 Million USD | -67.44% |
| 1997 Q2 | 3.8 Million USD | 23.33% |
| 1997 FY | - USD | -16.95% |
| 1997 Q1 | 3 Million USD | -6.25% |
| 1996 FY | - USD | 47.5% |
| 1996 Q4 | 3.3 Million USD | -3.03% |
| 1996 Q3 | 3.4 Million USD | 26.92% |
| 1996 Q2 | 2.9 Million USD | 4.0% |
| 1996 Q1 | 2.5 Million USD | 19.05% |
| 1995 Q2 | 1.9 Million USD | -11.11% |
| 1995 FY | - USD | 33.33% |
| 1995 Q4 | 2.2 Million USD | -19.23% |
| 1995 Q3 | 2.6 Million USD | 62.5% |
| 1995 Q1 | 1.9 Million USD | -25.0% |
| 1994 FY | - USD | 185.71% |
| 1994 Q1 | 1.2 Million USD | 12.5% |
| 1994 Q2 | 1.5 Million USD | 55.56% |
| 1994 Q3 | 1.7 Million USD | 0.0% |
| 1994 Q4 | 2.4 Million USD | 71.43% |
| 1993 Q3 | 700 Thousand USD | 20.0% |
| 1993 Q4 | 1 Million USD | 33.33% |
| 1993 Q2 | 700 Thousand USD | -88.37% |
| 1993 Q1 | 4.3 Million USD | 138.05% |
| 1993 FY | - USD | 132.31% |
| 1992 Q1 | 2 Million USD | 114.6% |
| 1992 Q4 | -11.3 Million USD | -570.83% |
| 1992 FY | - USD | 38.1% |
| 1992 Q3 | 2.4 Million USD | 4.35% |
| 1992 Q2 | 2.3 Million USD | 15.0% |
| 1991 Q4 | -13.7 Million USD | -1812.5% |
| 1991 Q1 | -1.3 Million USD | 92.82% |
| 1991 Q2 | 900 Thousand USD | 169.23% |
| 1991 FY | - USD | 25.53% |
| 1991 Q3 | 800 Thousand USD | -11.11% |
| 1990 FY | - USD | -422.22% |
| 1990 Q1 | 6.2 Million USD | 189.86% |
| 1990 Q2 | 6.3 Million USD | 1.61% |
| 1990 Q4 | -18.1 Million USD | -1306.67% |
| 1990 Q3 | 1.5 Million USD | -76.19% |
| 1989 Q4 | -6.9 Million USD | -727.27% |
| 1989 Q1 | 1.1 Million USD | 114.1% |
| 1989 Q2 | 1.1 Million USD | 0.0% |
| 1989 Q3 | 1.1 Million USD | 0.0% |
| 1989 FY | - USD | -107.69% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 172.802% |
| AngioDynamics, Inc. | -14.29 Million USD | 332.445% |
| AtriCure, Inc. | -8.1 Million USD | 509.681% |
| Avinger, Inc. | -16.34 Million USD | 303.236% |
| Azenta, Inc. | 55.15 Million USD | 39.764% |
| BioLife Solutions, Inc. | -45.23 Million USD | 173.436% |
| The Cooper Companies, Inc. | 882.8 Million USD | 96.237% |
| Daxor Corporation | 329.74 Thousand USD | -9974.908% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 351.712% |
| Femasys Inc. | -13.16 Million USD | 352.259% |
| GlucoTrack, Inc. | -7.09 Million USD | 568.495% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -249.953% |
| Hologic, Inc. | 1.29 Billion USD | 97.437% |
| ICU Medical, Inc. | 307.69 Million USD | 89.203% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 98.612% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 453.43% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 32.188% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 605.252% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 605.252% |
| Masimo Corporation | 236.7 Million USD | 85.965% |
| Microbot Medical Inc. | -10.63 Million USD | 412.404% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -110.652% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 85.646% |
| Nephros, Inc. | -1.37 Million USD | 2509.065% |
| NovoCure Limited | -175.86 Million USD | 118.89% |
| NEXGEL, Inc. | -2.73 Million USD | 1316.886% |
| NEXGEL, Inc. | -2.73 Million USD | 1316.886% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 138.408% |
| OraSure Technologies, Inc. | 76.15 Million USD | 56.379% |
| Pro-Dex, Inc. | 8.33 Million USD | -298.668% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 178.412% |
| Predictive Oncology Inc. | -13.18 Million USD | 352.018% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 1422.518% |
| QuidelOrtho Corporation | 545.6 Million USD | 93.911% |
| Repligen Corporation | 124.29 Million USD | 73.272% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 11591.299% |
| Sharps Technology, Inc. | -8.98 Million USD | 469.928% |
| Utah Medical Products, Inc. | 24.8 Million USD | -33.929% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 85.681% |
| Jin Medical International Ltd. | 3.44 Million USD | -864.918% |